ArticleJTO clinical and research reports2020

Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population.

Tamkin Ahmadzada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.